Quantitative FMISO imaging to assess regional tumor hypoxia as a predictor of response to therapy.

被引：0
|
作者：
Muzi, Mark [1 ]
O'Sullivan, Janet [2 ]
Eary, Janet F. [1 ]
Krohn, Kenneth A. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Natl Univ Ireland Univ Coll Cork, Cork, Ireland
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B149
引用
收藏
页数：1
相关论文
共 50 条
  • [41] IMAGING OF HYPOXIA MARKERS TO PREDICT RESPONSE OF PHOTODYNAMIC THERAPY
    Mallidi, Srivalleesha
    Ichikawa, Megumi
    Mai, Zhiming
    Khan, Amjad
    Hasan, Tayyaba
    LASERS IN SURGERY AND MEDICINE, 2016, 48 : 54 - 55
  • [42] Simultaneous Imaging of Tumor Hypoxia and Proliferation in Glioblastoma using Dual[18FMISO+18FLT] Dynamic PET
    Nehmeh, Sadek
    Magge, Rajiv
    Schwartz, Theodore
    Fine, Howard
    Liechty, Benjamin
    Schuck, Phelipi
    Calimag, William
    Kadrmas, Dan
    Schwartz, Jazmin
    Ivanidze, Jana
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [43] Quantitative Imaging for Evaluation of Response to Cancer Therapy
    Clarke, Laurence P.
    Croft, Barbara S.
    Nordstrom, Robert
    Zhang, Huiming
    Kelloff, Gary
    Tatum, J.
    TRANSLATIONAL ONCOLOGY, 2009, 2 (04): : 195 - 197
  • [44] Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response
    Timm, Kerstin N.
    Kennedy, Brett W. C.
    Brindle, Kevin M.
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5196 - 5203
  • [45] Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET
    Arvold, Nils D.
    Heidari, Pedram
    Kunawudhi, Anchisa
    Sequist, Lecia V.
    Mahmood, Umar
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (02) : 234 - 242
  • [46] Bladder tumor metabolic alterations in response to IFN[alpha] gene therapy.
    Miest, Tanner
    Mitra, Anirban P.
    Narayan, Vikram M.
    Dinney, Colin P. N.
    Mokkapati, Sharada
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [47] Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy.
    Efstathiou, Jason A.
    Gibb, Ewan
    Miyamoto, David Tomoaki
    Wu, Chin-Lee
    Drumm, Michael
    Lehrer, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [48] How Do We Couple Quantitative Imaging and Models of Tumor Response to Improve Multimodality Therapy?
    Marks, L.
    Moiseenko, V.
    Stewart, R.
    Jeraj, R.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [49] Diurnal rhythm of serum NTX: A new marker to assess bone resorption and response to therapy.
    Greenspan, SL
    Holland, S
    Yuan, W
    Kher, U
    Clemens, D
    Gertz, B
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T570 - T570
  • [50] Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO
    Nakajima, Kohei
    Homma, Mitsunori
    Suzuki, Motofumi
    Yokouchi, Yuta
    Matsuda, Takuma
    Takakura, Hideo
    Hirata, Kenji
    Kuge, Yuji
    Ogawa, Mikako
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : 85 - 92
12345